Stifel Nicolaus Issues Positive Forecast for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGLGet Free Report) had its price target lifted by research analysts at Stifel Nicolaus from $2.00 to $3.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price objective points to a potential downside of 10.42% from the stock’s current price.

AGL has been the topic of a number of other reports. Barclays cut their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a report on Wednesday. Sanford C. Bernstein lifted their price target on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a report on Wednesday, January 15th. TD Cowen reduced their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Citigroup raised agilon health from a “sell” rating to a “neutral” rating and raised their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $4.10.

View Our Latest Research Report on AGL

agilon health Trading Down 7.7 %

NYSE AGL opened at $3.35 on Wednesday. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -3.37 and a beta of 0.66. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The business’s fifty day moving average is $2.89 and its 200 day moving average is $3.04.

Insider Buying and Selling

In related news, Director Karen Mcloughlin acquired 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the company’s stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 77,500 shares of company stock worth $169,600 in the last quarter. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of hedge funds have recently bought and sold shares of AGL. Los Angeles Capital Management LLC purchased a new stake in shares of agilon health in the third quarter valued at about $513,000. Aigen Investment Management LP bought a new stake in agilon health in the 3rd quarter worth about $79,000. Simplify Asset Management Inc. increased its stake in agilon health by 67.5% in the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company’s stock valued at $663,000 after buying an additional 67,968 shares during the last quarter. Intech Investment Management LLC purchased a new stake in agilon health in the 3rd quarter valued at about $228,000. Finally, Citigroup Inc. boosted its stake in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.